Four Decades for Justice
On March 12, 2010, the United States Court of Appeals for the Third Circuit affirmed the District Court for the Eastern District of Pennsylvania’s dismissal of a lawsuit against Cravath clients Crown Finance Foundation and Altimo Holdings & Investments Limited (and an unrelated defendant) alleging defamation and intentional interference with prospective contractual relations. Plaintiffs’ claims stemmed from an open letter and attachments sent by Altimo’s chairman to Telenor, a company with which Altimo and its affiliates were involved in multiple disputes. Plaintiffs alleged that the letter and attachments, disseminated to worldwide media and summarized in Russian Internet news articles, defamed them by implicating them in a negative public relations campaign spearheaded by Telenor against Altimo and its parent, Alfa Group. The district court dismissed the allegation for lack of personal jurisdiction and, in a non-precedential opinion, the Third Circuit affirmed, finding that the factual allegations in the complaint didn’t support the plaintiffs’ conclusory allegations that the defendants aimed their conduct at Pennsylvania.
The Cravath lawyers involved in this matter include partner Ronald S. Rolfe and associate Timothy K. Kline.
Deals & Cases
February 05, 2024
Cravath represented Artivion, Inc. in connection with $350 million of credit facilities obtained from Ares Management Credit funds to comprehensively address its debt maturities. Artivion is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with aortic diseases. The facilities consisted of a $190 million secured term loan facility, a $100 million secured delayed draw term loan facility and a $60 million secured revolving credit facility. The transaction closed on January 18, 2024.
Deals & Cases
February 01, 2023
Cravath represented Monogram Health Holdings, Inc. in connection with its $375 million Series C financing round, consisting of a private placement of series C preferred stock. Monogram Health Holdings is the parent company of Monogram Health, Inc., a leading kidney‑disease‑focused benefit management and care delivery company. The transaction closed on December 23, 2022.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.